Literature DB >> 9095200

A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket.

L Tong1, S Pav, D M White, S Rogers, K M Crane, C L Cywin, M L Brown, C A Pargellis.   

Abstract

The crystal structure of human p38 mitogen-activated protein (MAP) kinase in complex with a potent and highly specific pyridinyl-imidazole inhibitor has been determined at 2.0 A resolution. The structure of the kinase, which is in its unphosphorylated state, is similar to that of the closely-related ERK2. The inhibitor molecule is bound in the ATP pocket. A hydrogen bond is made between the pyridyl nitrogen of the inhibitor and the main chain amido nitrogen of residue 109, analogous to the interaction from the N1 atom of ATP. The crystal structure provides possible explanations for the specificity of this class of inhibitors. Other protein kinase inhibitors may achieve their specificity through a similar mechanism. The structure also reveals a possible second binding site for this inhibitor, with currently unknown function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9095200     DOI: 10.1038/nsb0497-311

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  75 in total

1.  Low-density lipoprotein activates the small GTPases Rap1 and Ral in human platelets.

Authors:  C M Hackeng; B Franke; I A Relou; G Gorter; J L Bos; H J van Rijn ; J W Akkerman
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

Review 2.  Protein kinases as therapeutic targets.

Authors:  R Sridhar; O Hanson-Painton; D R Cooper
Journal:  Pharm Res       Date:  2000-11       Impact factor: 4.200

3.  The Usf-1 transcription factor is a novel target for the stress-responsive p38 kinase and mediates UV-induced Tyrosinase expression.

Authors:  M D Galibert; S Carreira; C R Goding
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

4.  An efficient proteomics method to identify the cellular targets of protein kinase inhibitors.

Authors:  Klaus Godl; Josef Wissing; Alexander Kurtenbach; Peter Habenberger; Stephanie Blencke; Heidrun Gutbrod; Kostadinos Salassidis; Matthias Stein-Gerlach; Andrea Missio; Matt Cotten; Henrik Daub
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

5.  Virtual screening using a conformationally flexible target protein: models for ligand binding to p38α MAPK.

Authors:  Natalie B Vinh; Jamie S Simpson; Peter J Scammells; David K Chalmers
Journal:  J Comput Aided Mol Des       Date:  2012-04-20       Impact factor: 3.686

6.  Structural determinants of PERK inhibitor potency and selectivity.

Authors:  Hong Wang; Jaime Blais; David Ron; Timothy Cardozo
Journal:  Chem Biol Drug Des       Date:  2010-12       Impact factor: 2.817

7.  Sepsis-induced changes in macrophage co-stimulatory molecule expression: CD86 as a regulator of anti-inflammatory IL-10 response.

Authors:  Sarah Newton; Yanli Ding; Chun-Shiang Chung; Yaping Chen; Joanne L Lomas-Neira; Alfred Ayala
Journal:  Surg Infect (Larchmt)       Date:  2004       Impact factor: 2.150

8.  Loss of signal transducer and activator of transduction 4 or 6 signaling contributes to immune cell morbidity and mortality in sepsis.

Authors:  Grace Y Song; Chun-Shiang Chung; Rebecca J Rhee; William G Cioffi; Alfred Ayala
Journal:  Intensive Care Med       Date:  2005-09-20       Impact factor: 17.440

9.  Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor.

Authors:  Paula Monje; Maria Julia Marinissen; J Silvio Gutkind
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

10.  A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase.

Authors:  T Fox; J T Coll; X Xie; P J Ford; U A Germann; M D Porter; S Pazhanisamy; M A Fleming; V Galullo; M S Su; K P Wilson
Journal:  Protein Sci       Date:  1998-11       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.